SE9904863D0 - New use - Google Patents

New use

Info

Publication number
SE9904863D0
SE9904863D0 SE9904863A SE9904863A SE9904863D0 SE 9904863 D0 SE9904863 D0 SE 9904863D0 SE 9904863 A SE9904863 A SE 9904863A SE 9904863 A SE9904863 A SE 9904863A SE 9904863 D0 SE9904863 D0 SE 9904863D0
Authority
SE
Sweden
Prior art keywords
drug
growth factor
new use
nerve growth
administrated
Prior art date
Application number
SE9904863A
Other languages
English (en)
Inventor
Thomas Lundeberg
Original Assignee
Medscand Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medscand Medical Ab filed Critical Medscand Medical Ab
Priority to SE9904863A priority Critical patent/SE9904863D0/sv
Publication of SE9904863D0 publication Critical patent/SE9904863D0/sv
Priority to AU27198/01A priority patent/AU2719801A/en
Priority to PCT/SE2000/002698 priority patent/WO2001049313A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9904863A 1999-12-30 1999-12-30 New use SE9904863D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use
AU27198/01A AU2719801A (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders
PCT/SE2000/002698 WO2001049313A1 (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use

Publications (1)

Publication Number Publication Date
SE9904863D0 true SE9904863D0 (sv) 1999-12-30

Family

ID=20418378

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use

Country Status (3)

Country Link
AU (1) AU2719801A (sv)
SE (1) SE9904863D0 (sv)
WO (1) WO2001049313A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366222A1 (en) * 2001-11-19 2003-06-10 Novartis Ag Use of an ascomycin for the treatment of blepharitis
ATE545429T1 (de) 2002-12-20 2012-03-15 Lundbeck & Co As H Modulation der neurotrophinaktivität;screeningsverfahren
LT3225251T (lt) 2006-12-21 2020-04-10 H. Lundbeck A/S Proneurotrofinų veiklos moduliavimas
AU2008339904A1 (en) * 2007-12-20 2009-07-02 Cytos Biotechnology Ag Nerve growth factor conjugates and uses thereof
EP2800606A4 (en) * 2012-01-05 2015-07-15 Beech Tree Labs Inc METHOD OF TREATING PAIN BY ADMINISTERING NERVE GROWTH FACTOR

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242564A (ja) * 1994-03-02 1995-09-19 Sagami Chem Res Center 骨形成促進剤
CA2286137A1 (en) * 1997-04-11 1998-10-22 Roche Diagnostics Gmbh Ngf for the prevention of demyelination in the nervous system
EP1078093B1 (en) * 1998-02-27 2011-06-08 The Trustees of The University of Pennsylvania Vaccines, immunotherapeutics and methods for using the same

Also Published As

Publication number Publication date
AU2719801A (en) 2001-07-16
WO2001049313A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
EP1605956A4 (en) ADMINISTRATION OF CAPSAICINOIDES
ATE401874T1 (de) Verabreichung von capsaicinoiden
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE119386T1 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
EA200701131A1 (ru) Гелеобразная препаративная форма капсаициноида и способы её применения
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
DE69621243D1 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DK1343472T3 (da) Thixotropisk næsespray
SE9904863D0 (sv) New use
EA200001246A1 (ru) Карбамиды и карбаматы n-гетероциклических карбоновых кислот и изостер карбоновых кислот
DE69822276T2 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ATE373482T1 (de) Pharmazeutische zusammensetzung zur lokalen behandlung von hauterkrankungen und hautwunden
US9775995B2 (en) Treating skin ulcers
DE69900774T2 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE358490T1 (de) Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen
ATE291919T1 (de) Verwendung von adatanserin zur behandlung von akuten neurodegenerativen erkrankungen
SE9803276D0 (sv) Use of certain drugs for treating nerve root injury